Envisagenics last raised $19.2M in its Early Stage VC (Sep 2021).
- ·The complete investor list: 24 names
- ·Watch Envisagenics: the Monday email on marks, rounds and moves
Envisagenics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2021 | Early Stage VC | $19.2M | ▮ | ▮ |
| Mar 2017 | Seed Round | $2.5M | ▮ | ▮ |
Membership and data by Private Market View
Envisagenics valuation
Envisagenics's last known valuation is $150 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Envisagenics raised?
Envisagenics has raised $40.5 million in total; 2 of its rounds are on record. The largest on record was a $2.5 million seed round in Mar 2017; the most recent was a $19.2 million early-stage round in Sep 2021.
Envisagenics has filed 3 Form Ds with the SEC since 2017, most recently in Oct 2021 ($19.2 million sold to 24 investors).
How Envisagenics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Envisagenics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Envisagenics
- What is Envisagenics worth?
- Envisagenics's last known valuation is $150.0M.
- How much has Envisagenics raised?
- Envisagenics has raised $40.5M in total funding across 2 recorded rounds.
- When did Envisagenics last raise?
- Envisagenics last raised in Sep 2021 (Early Stage VC), raising $19.2M.